Tag: Pfizer
-
Abcam Joins Innovative Health Initiative’s LIGAND-AI Project to Accelerate AI-Driven Drug Discovery Through Open Science
Abcam Partners in a Groundbreaking Open-Science Initiative Abcam has joined an industry-academic collaboration that aims to accelerate AI-driven drug discovery through open science. The initiative is led by the Structural Genomics Consortium (SGC) in partnership with Pfizer and sits under the umbrella of the Innovative Health Initiative (IHI). With a budget of more than €60…
-
Abcam Joins Innovative Health Initiative’s LIGAND-AI Project to Accelerate AI-Driven Drug Discovery
A Strategic Collaboration to Accelerate AI-Driven Drug Discovery Abcam has joined the Innovative Health Initiative’s (IHI) LIGAND-AI project, a collaborative effort designed to speed up AI-powered drug discovery through an open-science framework. The public-private partnership is led by the Structural Genomics Consortium (SGC) in collaboration with Pfizer, and it brings together industry, academia, and non-profit…
-
Abcam joins LIGAND-AI to accelerate AI-driven drug discovery
Abcam joins LIGAND-AI to advance AI-driven drug discovery Abcam has joined the Innovative Health Initiative (IHI) LIGAND-AI project, a bold partnership designed to accelerate drug discovery using artificial intelligence and open science. The collaboration brings together industry leaders, academic researchers, and public-private investment with a funding pool exceeding €60 million. The initiative is steered by…
-
Markets Today: Trump Tariffs, Urso Says Data Will Reveal Impact
Markets Today: European stocks rise as Wall Street data and tariff developments weigh on sentiment European equities edged higher as traders absorbed the latest signals from U.S. tariff policy and watched for the annual data that could clarify which sectors are most exposed. Italy’s Industry Minister Adolfo Urso underscored a cautious, data-driven approach, saying we…